Dr. Garima Gupta, MD

Dr. Gupta practices at Fort Wayne South Dialysis in Oak Brook, Illinois.

Dr. Gupta's NPI, 1073729125, was assigned on May 15, 2007. Dr. Gupta holds Indiana license 01066542A.

Dr. Gupta's primary practice is Fort Wayne South Dialysis, at 120 W 22nd St, Oak Brook, IL 60523 in Dupage County. The practice phone is (260) 456-0451.

Dr. Gupta's primary practice is Fort Wayne South Dialysis in Oak Brook, Illinois. Dr. Gupta is also affiliated with Parkview Regional Medical Center. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Gupta to 4 more hospitals, 5 dialysis centers, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gupta practices, 13 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Gupta's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gupta is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Gupta's licenses on file in 2 states: Indiana and Ohio.

CMS data shows 1,598 Medicare services from Dr. Gupta across 28 procedure codes in 2024, for 415 Medicare patients. Medicare paid $116,744 for them.

CMS counts 415 Medicare patients who saw Dr. Gupta in 2024. The largest group is 75 to 84, with 148 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 4.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gupta's median patient age at 71, with 47% women.

In 2024, Dr. Gupta wrote 2,079 Medicare Part D claims for 301 patients. 90% of them were for generic drugs. CMS names the drug for 1,862 of them, across 38 drugs with 11 or more claims each, at $184,825 in total drug cost. In 2023, CMS named 1,807 claims across 34 drugs.

Dr. Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gupta as offering telehealth.

Dmand AI links 92 papers to Dr. Gupta, published from 2010 to 2025. 2025 was the busiest year, with 22. The most frequent topics are Drug Delivery Systems, Antineoplastic Agents and Nanoparticles. Dr. Gupta has published most often in Int J Pharm. Dr. Gupta's most frequent co-authors are Mehmet Akce, MD, Bassel Fouad El-Rayes, MD and Midhun Malla, MD.

CMS Open Payments shows 261 general payments to Dr. Gupta from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. AstraZeneca Pharmaceuticals LP paid the most, $744. It also lists 1 research payment totaling $1,729 in 2025.